Blade Therapeutics' $353M SPAC Go-Public Deal Called Off
Law 360 M&A
JUNE 13, 2022
Blank-check company Biotech Acquisition Co. and biopharmaceutical group Blade Therapeutics Inc. said Monday they are canceling their previously announced nearly $353 million merger, marking the latest in a number of special-purpose acquisition company transactions that have been terminated recently.
52 
Let's personalize your content